Investor Presentaiton
op ajanta pharma limited
INVESTOR PRESENTATION
Q2 FY 2023 3rd November 2022
Safe Harbor Statement
This presentation may include certain 'forward looking statements', based on current expectations, forecasts and assumptions within
the meaning of applicable laws and regulations. They are subject to risks and uncertainties which could cause actual outcomes and
results to differ materially from these statements.
The Company disclaims any obligation to revise any forward-looking statements. The readers may use their own judgment and are
advised to make their own calculations before deciding on any matter based on the information given herein.
This material is used during oral presentation; it is not a complete record of the discussion.
ajanta
2 of 37
1View entire presentation